stars 1 stars 2 stars 3

At AVaTAR MedTech, we have developed a surgical method and a set of medical devices specifically designed to reconstruct the aortic or pulmonary valve in pediatric patients. The new valve is made of autologous tissue, is perfectly symmetrical and functional, and has also the ability to accommodate growth of pediatric patients. This innovative approach enables a straightforward and reproducible implantation procedure for the surgeon, while ensuring safety and good function of the new valve for the patient.

AVaTAR MedTech Questions

Tomás Armendariz is the CEO and Co-Founder of AVaTAR MedTech.

6 people are employed at AVaTAR MedTech.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users